By Conjoint Professor Dedee Frances Murrell

Journal articles

Walter S; Murrell DF; Pratama R; Kizny Gordon AE; McIver CJ, 2025, 'Assessment of a Real-Time PCR Assay for the Detection of Dermatophytosis by Sampling With an Adhesive Tape Technique', Australasian Journal of Dermatology, 66, pp. e60 - e61, http://dx.doi.org/10.1111/ajd.14415

Zhou AE; Jain NP; Gronbeck C; Sloan B; Murrell DF; Grant-Kels JM, 2025, 'Ethics of publication mills and payment for guaranteed authorships', Journal of the American Academy of Dermatology, 92, pp. 666 - 667, http://dx.doi.org/10.1016/j.jaad.2024.10.034

Walter S; Murrell DF, 2025, 'Toward gender equity for all members of the academic dermatology community', Clinics in Dermatology, 43, pp. 248 - 250, http://dx.doi.org/10.1016/j.clindermatol.2025.01.004

He A; Koszegi B; Uzun S; Bilgic A; Bozca BC; Yang B; Daneshpazhooh M; Boziou M; Patsatsi A; Kakuta R; Takahashi H; Nery D; Mundin C; Ramirez-Quizon M; Culton D; McAlpine S; Johal J; Shulruf B; Stone JH; Murrell DF, 2025, 'Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathy', Journal of the European Academy of Dermatology and Venereology, 39, pp. 340 - 349, http://dx.doi.org/10.1111/jdv.20149

Murrell DF, 2025, 'Body image disturbance has severe psychosocial impacts in patients suffering from autoimmune blistering diseases', Journal of the European Academy of Dermatology and Venereology, 39, pp. 253 - 254, http://dx.doi.org/10.1111/jdv.20491

Werth VP; Murrell DF; Joly P; Ardeleanu M; Hultsch V, 2025, 'Bullous pemphigoid burden of disease, management and unmet therapeutic needs', Journal of the European Academy of Dermatology and Venereology, 39, pp. 290 - 300, http://dx.doi.org/10.1111/jdv.20313

Stark M; Sheriff T; Murrell DF, 2025, 'Efficacy of adalimumab for Hailey-Hailey disease demonstrated by reduction of the Pemphigus Disease Area Index', Jaad Case Reports, 56, pp. 87 - 89, http://dx.doi.org/10.1016/j.jdcr.2024.11.025

Yang A; Sarsam S; Murrell DF, 2025, 'Linear IgA Bullous Dermatosis in Adults and Children: A Narrative Review of Literature on Disease Distribution and Evaluation of Existing Scoring Tools', Acta Dermatovenerologica Croatica, 33

Murrell DF; Bodán R; Kern JS, 2025, 'Oleogel-S10 (birch bark extract) for the treatment of epidermolysis bullosa: plain language summary of the EASE study', Future Rare Diseases, 5, http://dx.doi.org/10.1080/23995270.2025.2591643

Krastev D; Drenovska K; Shahid M; Valeva E; Ren Z; Murrell D; Vassileva S, 2025, '121 Quality of life in Bulgarian patients with autoimmune blistering diseases: ABQOL & TABQOL validation', Journal of Investigative Dermatology, 145, pp. S287 - S287, http://dx.doi.org/10.1016/j.jid.2025.10.125

Bruckner A; Kiritsi D; Murrell D; Lee LW; Sprecher E; Maher L; Löwe S; Kern J, 2025, '124: Oleogel-S10 reduces dressing changes burden and associated costs in patients with epidermolysis bullosa', Journal of Investigative Dermatology, 145, pp. e30, http://dx.doi.org/10.1016/j.jid.2025.02.127

Tseng H; Frew J; Murrell D, 2025, '65 Statin Therapy Is Associated With a Reduced Risk of Autoimmune Blistering Diseases: A Global Retrospective Cohort Study of 172 Million Individuals', Journal of Investigative Dermatology, 145, pp. e42, http://dx.doi.org/10.1016/j.jid.2025.09.083

Haag C; Alexis A; Aoki V; Bissonnette R; Blauvelt A; Chovatiya R; Cork MJ; Danby SG; Eichenfield LF; Eyerich K; Gooderham M; Guttman-Yassky E; Hijnen DJ; Irvine AD; Katoh N; Murrell DF; Leshem YA; Levin AA; Vittrup I; Olydam JI; Orfali RL; Paller AS; Renert-Yuval Y; Rosmarin D; Silverberg JI; Thyssen JP; Ständer S; Stefanovic N; Todd G; Yu JD; Simpson EL, 2024, 'A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema Council', British Journal of Dermatology, 192, pp. 135 - 143, http://dx.doi.org/10.1093/bjd/ljae342

Hachem ME; Diociaiuti A; Zambruno G; Samela T; Ferretti F; Carnevale C; Linertová R; Bodemer C; Murrell DF; Abeni D, 2024, '“Quality of Life in Epidermolysis Bullosa” and “Epidermolysis Bullosa Burden of Disease”: Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires', Italian Journal of Pediatrics, 50, http://dx.doi.org/10.1186/s13052-024-01657-2

Akbarialiabad H; Murrell DF, 2024, 'A new dawn for orphan diseases in dermatology: The transformative potential of digital twins', Journal of the European Academy of Dermatology and Venereology, 38, pp. 2309 - 2310, http://dx.doi.org/10.1111/jdv.20062

Akbarialiabad H; Pasdar A; Murrell DF, 2024, 'Digital twins in dermatology, current status, and the road ahead', Npj Digital Medicine, 7, http://dx.doi.org/10.1038/s41746-024-01220-7

Sarsam S; Murrell DF, 2024, 'Interleukin-17 inhibitors for the management of severe rosacea', Australasian Journal of Dermatology, 65, pp. 660 - 662, http://dx.doi.org/10.1111/ajd.14377

Werth VP; Murrell DF; Joly P; Heck R; Orengo JM; Ardeleanu M; Hultsch V, 2024, 'Pathophysiology of Bullous Pemphigoid: Role of Type 2 Inflammation and Emerging Treatment Strategies (Narrative Review)', Advances in Therapy, 41, pp. 4418 - 4432, http://dx.doi.org/10.1007/s12325-024-02992-w

Victory L; Murrell DF, 2024, 'The future of digital pills and their potential use in dermatological clinical trials', Journal of the European Academy of Dermatology and Venereology, 38, pp. 2314 - 2315, http://dx.doi.org/10.1111/jdv.20224

Akbarialiabad H; Grant-Kels JM; Murrell DF, 2024, 'A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists', Clinics in Dermatology, 42, pp. 723 - 726, http://dx.doi.org/10.1016/j.clindermatol.2024.05.008

Tseng H; Stone C; Shulruf B; Murrell DF, 2024, 'Establishing minimal clinically important differences for the Pemphigus Disease Area Index', British Journal of Dermatology, 191, pp. 823 - 831, http://dx.doi.org/10.1093/bjd/ljae283

Kiritsi D; Schauer F; Gewert S; Reineker K; Reimer-Taschenbrecker A; Schwieger-Briel A; Ott H; Schmoor C; Grishina O; Murrell D; Stiller B; Zahn T; Nyström A; Bruckner-Tuderman L, 2024, 'Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trial', Eclinicalmedicine, 77, http://dx.doi.org/10.1016/j.eclinm.2024.102900

Wong PC; Wang MA; Ng TJ; Akbarialiabad H; Murrell DF, 2024, 'Keratosis pilaris treatment paradigms: Assessing effectiveness across modalities', Clinical and Experimental Dermatology, 49, pp. 1105 - 1117, http://dx.doi.org/10.1093/ced/llae066

Rademaker M; Jarrett P; Murrell DF; Sinclair RD; Pasfield L; Poppelwell D; Shumack S, 2024, 'Cross-sectional burden-of-illness study in atopic dermatitis (MEASURE-AD) in Australia and New Zealand reveals impacts on well-being', Australasian Journal of Dermatology, 65, pp. e145 - e155, http://dx.doi.org/10.1111/ajd.14308

Bai H; Lin G; Kantor J; Elston D; Grant-Kels JM; Murrell DF; Murase JE, 2024, 'Dermatology Journal Advisory Boards and editorial independence', Jaad International, 16, pp. 224 - 236, http://dx.doi.org/10.1016/j.jdin.2023.08.001

Akbarialiabad H; Grant-Kels JM; Murrell DF, 2024, 'Letter to the editor in reply to “A call for action: Formalin exposure and broader occupational hazards and assessing the risk of glioblastoma in clinician scientists”', Clinics in Dermatology, 42, pp. 526 - 527, http://dx.doi.org/10.1016/j.clindermatol.2024.07.002

Koszegi B; Stone C; Ishii N; Hashimoto T; Murrell DF, 2024, 'Sustained clinical remission for 5 years in severe epidermolysis bullosa acquisita following rituximab infusions', Journal of the European Academy of Dermatology and Venereology, 38, pp. e747 - e749, http://dx.doi.org/10.1111/jdv.19863

Korte EWH; Pasmooij AMG; Bolling MC; Hickey S; Hussain S; Kiritsi D; Kottner J; Prinsen CAC; Sauvestre A; Sendin G; Spuls PI; Tarrats N; Wally V; Welponer T; Laimer M; Van Den Akker PC; Bardhan A; Bataille P; Bodemer C; Bolling M; Bruckner A; Chiaverini C; Clemett V; Collins C; Colmant C; De Rosa L; Duipmans J; Ebens C; Fernandez MF; Gorell E; Guez S; Has C; Hsu CK; Jain R; Kenny T; Kern JS; Khanna D; Kitzmüller S; Lara-Corrales I; Lee M; Li W; Lospalluti L; Marinkovich MP; Martinez A; Mellerio J; Moss C; Mullins O; Murrell D; Ott H; Palisson F; Paller A; Pasmooij M; Petrof G; Pope E; Salamon G; Salas-Alanis J; Salavastru C; Scherer S; Schräder N; Sprecher E; Spreitzer C; Tarrats N; Wertheim-Tysarowska K; Zahn T, 2024, 'Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa', British Journal of Dermatology, 191, pp. 463 - 465, http://dx.doi.org/10.1093/bjd/ljae200

Murrell DF; Ferrucci SM; Foti C; Perez-Garcia B; Lapeere H; Calzavara-Pinton P; Fougerousse A-C; Wu J; Ardeleanu M; Bosman K, 2024, '634 - Patient-reported outcomes and safety in adolescent and adult atopic dermatitis patients treated with dupilumab: real-world insights one year into the GLOBOSTAD multinational prospective observational study', British Journal of Dermatology, 191, pp. ljae266.016, http://dx.doi.org/10.1093/bjd/ljae266.016

Murrell DF; Caux F; Patsatsi A; Hagino O; Rudnicka L; Vassileva S; Uzun S; Ye J; Yen K; Arora P; Gourlay SG; Joly P; Werth VP, 2024, 'Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study', Journal of Investigative Dermatology, 144, pp. 1762 - 1771.e6, http://dx.doi.org/10.1016/j.jid.2024.02.023

Walter S; Murrell DF, 2024, 'Gender equity in academic dermatology: Problems aplenty, yet paths ahead', Journal of the European Academy of Dermatology and Venereology, 38, pp. 1504 - 1513, http://dx.doi.org/10.1111/jdv.20027

Cowan TL; Sundberg JP; Roopenian DC; Sproule TJ; Murrell DF, 2024, 'Phenotypic differences in intermediate generalized junctional epidermolysis bullosa with homozygous LAMC2 mutation and a potential genetic modifier', Journal of the European Academy of Dermatology and Venereology, 38, pp. e719 - e721, http://dx.doi.org/10.1111/jdv.19859

Murrell DF; Joly P; Werth VP; Ujiie H; Worm M; Mangold AR; Avetisova E; Maloney J; Laws E; Mortensen E; Dubost-Brama A; Shabbir A, 2024, 'Correction to: Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT (Advances in Therapy, (2024), 41, 7, (2991-3002), 10.1007/s12325-024-02810-3)', Advances in Therapy, 41, pp. 3014 - 3015, http://dx.doi.org/10.1007/s12325-024-02886-x

Murrell DF; Joly P; Werth VP; Ujiie H; Worm M; Mangold AR; Avetisova E; Maloney J; Laws E; Mortensen E; Dubost-Brama A; Shabbir A, 2024, 'Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT', Advances in Therapy, 41, pp. 2991 - 3002, http://dx.doi.org/10.1007/s12325-024-02810-3

Ferrucci SM; Calzavara-Pinton P; Murrell DF; Fougerousse A-C; Karlova I; Lapeere H; Holzer G; Al-Ahmad M; Chu C-Y; Foti C; Perez-Garcia B; Petrova A; Wu J; Ardeleanu M; Bosman K, 2024, 'Physician-assessed effectiveness, patient-reported outcomes, and safety in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study', BRITISH JOURNAL OF DERMATOLOGY, 191, pp. I56 - I57, http://dx.doi.org/10.1093/bjd/ljae090.115

Caux F; Patsatsi A; Karakioulaki M; Antiga E; Baselga E; Borradori L; Caproni M; Cardones AR; Chandran NS; Dräger S; Drenovska K; Goebeler M; Günther C; Hofmann SC; Ioannides D; Joly P; Marinović B; Mariotti EB; Marzano AV; Morel KD; Murrell DF; Prost C; Sárdy M; Setterfield J; Skiljevic D; Uzun S; Vassileva S; Zambruno G; Schmidt E, 2024, 'S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology', Journal of the European Academy of Dermatology and Venereology, 38, pp. 1006 - 1023, http://dx.doi.org/10.1111/jdv.19880

Schmidt E; Ludwig RJ; Caux F; Payne AS; Sadik CD; Hashimoto T; Murrell DF, 2024, 'Editorial: Pemphigus and pemphigoid diseases: in memoriam Detlef Zillikens', Frontiers in Immunology, 15, pp. 1426834, http://dx.doi.org/10.3389/fimmu.2024.1426834

Murrell DF, 2024, 'Palmar Erythema Associated with Natalizumab in a Patient with Multiple Sclerosis', Clinical Dermatology & Therapy, 10, pp. 1 - 4, http://dx.doi.org/10.24966/cdt-8771/100133

Koszegi B; Murrell DF, 2024, 'Dapsone for the management of severe epidermolysis bullosa simplex: A case report and evidence for a repurposing trial', Journal of the European Academy of Dermatology and Venereology, 38, pp. e420 - e421, http://dx.doi.org/10.1111/jdv.19646

Murrell DF; Daneshpazhooh M, 2024, 'Impairment of sexual function in patients with pemphigus', Journal of the European Academy of Dermatology and Venereology, 38, pp. 643 - 644, http://dx.doi.org/10.1111/jdv.19882

Navarrete-Dechent C; Ashique KT; Ingram JR; Rudnicka L; Gilaberte Y; Ring J; Murrell DF; Elston D; Thiers BH, 2024, 'The road to publication: Advice from journal editors', Journal of the American Academy of Dermatology, 90, pp. 707 - 710, http://dx.doi.org/10.1016/j.jaad.2023.11.038

Ferrucci SM; Calzavara-Pinton P; Murrell DF; Fougerousse A-C; Karlova I; Lapeere H; Holzer G; Al-Ahmad M; Chu C-Y; Foti C; Pérez-García B; Wu J; Ardeleanu M; Bosman K, 2024, '531 - Physician-assessed effectiveness and patient-reported outcomes in adult and adolescent patients with atopic dermatitis treated with dupilumab: real-world insights 1 year into the GLOBOSTAD multinational prospective observational study', British Journal of Dermatology, 190, pp. ii34 - ii34, http://dx.doi.org/10.1093/bjd/ljad498.036

Labbouz S; Khan S; Gohara M; Lucas J; Sarkar R; Murrell DF; Dodiuk-Gad RP, 2024, 'Meeting report: Women’s Dermatology Society Forum at the 25th World Congress of Dermatology, Singapore, 2023', International Journal of Women S Dermatology, 10, http://dx.doi.org/10.1097/JW9.0000000000000125

Vassileva S; Murrell DF; Culton DA; Ujiie H; Hertl M; Goebeler M; Sinha AA; Schmidt E; Stoykov I; Verheesen P; Borradori L; Werth VP; Joly P, 2024, 'Overview of Clinical Trials With Efgartigimod in Autoimmune Blistering Diseases: Pemphigus Vulgaris and Pemphigus Foliaceus (ADDRESS and ADDRESS+) and Bullous Pemphigoid (BALLAD and BALLAD+)', SKIN The Journal of Cutaneous Medicine, 8, pp. s345, http://dx.doi.org/10.25251/skin.8.supp.345

Stone C; Murrell DF, 2024, 'A Case of Hidradenitis Suppurativa Responsive to Testosterone Replacement Therapy', Indian Dermatology Online Journal, 15, pp. 854 - 855, http://dx.doi.org/10.4103/idoj.idoj_653_23

Stone C; Bertolotti A; Davey L; Murrell DF, 2024, 'Atypical fixed drug eruption in confetti due to paracetamol', Dermatologica Sinica, 42, pp. 160 - 161, http://dx.doi.org/10.4103/ds.DS-D-23-00161

Stone C; Bak G; Oh D; Zhao C; Venugopal S; Kumar K; Murrell DF, 2024, 'Environmental triggers of pemphigus vulgaris and bullous pemphigoid: a case control study', Frontiers in Medicine, 11, http://dx.doi.org/10.3389/fmed.2024.1441369

Murrell DF; Weinberg JM; Yamauchi PS; Abdelmaksoud A; Grabbe S; Goldust M, 2024, 'Predatory Conferences and Journals in Dermatology Are Black Widow Parties', Skinmed, 22, pp. 407 - 408

Tseng H; Stone C; Murrell DF, 2024, 'Scoring Criteria for Autoimmune Bullous Diseases: Utility, Merits, and Demerits', Indian Dermatology Online Journal, 15, pp. 732 - 738, http://dx.doi.org/10.4103/idoj.idoj_611_23

Tseng H; Murrell DF, 2024, 'The potential of Bruton’s tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease', Expert Opinion on Pharmacotherapy, 25, pp. 1657 - 1665, http://dx.doi.org/10.1080/14656566.2024.2393280

Back to profile page